{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:24:57Z","timestamp":1789878297494,"version":"4.0.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T00:00:00Z","timestamp":1389657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/nrneph.2013.280","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T11:36:57Z","timestamp":1389699417000},"page":"174-180","source":"Crossref","is-referenced-by-count":68,"title":["Cardiovascular complications in atypical haemolytic uraemic syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"Marina","family":"Noris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,14]]},"reference":[{"key":"BFnrneph2013280_CR1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris, M. & Remuzzi, G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 361, 1676\u20131687 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013280_CR2","first-page":"1154","volume-title":"Renal Pathology: Vol. 2: with Clinical and Functional Correlations","author":"G Remuzzi","year":"1994","unstructured":"Remuzzi, G., Ruggenenti, P. & Bertani, T. in Renal Pathology: Vol. 2: with Clinical and Functional Correlations (eds Tisher, C. G. & Brenner, B. M.) 1154\u20131184 (J. B. Lippincott Company, 1994)."},{"key":"BFnrneph2013280_CR3","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","volume":"23","author":"C Loirat","year":"2008","unstructured":"Loirat, C., Noris, M. & Fremeaux-Bacchi, V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr. Nephrol. 23, 1957\u20131972 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2013280_CR4","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris, M. et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin. J. Am. Soc. Nephrol. 5, 1844\u20131859 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2013280_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2006-939763","volume":"32","author":"M Galbusera","year":"2006","unstructured":"Galbusera, M., Noris, M. & Remuzzi, G. Thrombotic thrombocytopenic purpura\u2014then and now. Semin. Thromb. Hemost. 32, 81\u201389 (2006).","journal-title":"Semin. Thromb. Hemost."},{"key":"BFnrneph2013280_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy, G. G. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413, 488\u2013494 (2001).","journal-title":"Nature"},{"key":"BFnrneph2013280_CR7","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","volume":"87","author":"M Furlan","year":"1996","unstructured":"Furlan, M., Robles, R. & Lamie, B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87, 4223\u20134234 (1996).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-0609.2008.01112.x","volume":"81","author":"AS Wahla","year":"2008","unstructured":"Wahla, A. S. et al. Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review. Eur. J. Haematol. 81, 311\u2013316 (2008).","journal-title":"Eur. J. Haematol."},{"key":"BFnrneph2013280_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1600-0609.2008.01172.x","volume":"82","author":"DC Sane","year":"2009","unstructured":"Sane, D. C., Streer, N. P. & Owen, J. Myocardial necrosis in patients with thrombotic thrombocytopenic purpura: pathophysiology and rationale for specific therapy. Eur. J. Haematol. 82, 83\u201392 (2009).","journal-title":"Eur. J. Haematol."},{"key":"BFnrneph2013280_CR10","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","volume":"25","author":"M Sallee","year":"2010","unstructured":"Sallee, M. et al. Myocardial infarction is a complication of factor H-associated atypical HUS. Nephrol. Dial. Transplant. 25, 2028\u20132032 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013280_CR11","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","volume":"3","author":"JP Venables","year":"2006","unstructured":"Venables, J. P. et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med. 3, e431 (2006).","journal-title":"PLoS Med."},{"key":"BFnrneph2013280_CR12","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00467-012-2276-8","volume":"27","author":"R Vilalta","year":"2012","unstructured":"Vilalta, R. et al. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome. Pediatr. Nephrol. 27, 2323\u20132326 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2013280_CR13","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1542\/peds.2012-0903","volume":"131","author":"M Malina","year":"2013","unstructured":"Malina, M. et al. Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics 131, e331\u2013e335 (2013).","journal-title":"Pediatrics"},{"key":"BFnrneph2013280_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","volume":"55","author":"JC Davin","year":"2010","unstructured":"Davin, J. C. et al. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Am. J. Kidney Dis. 55, 708\u2013711 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2013280_CR15","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/ndt\/gfq319","volume":"25","author":"C Loirat","year":"2010","unstructured":"Loirat, C. et al. Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation. Nephrol. Dial. Transplant. 25, 3421\u20133425 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013280_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/adc.76.6.518","volume":"76","author":"TJ Neuhaus","year":"1997","unstructured":"Neuhaus, T. J., Calonder, S. & Leumann, E. P. Heterogeneity of atypical haemolytic uraemic syndromes. Arch. Dis. Child. 76, 518\u2013521 (1997).","journal-title":"Arch. Dis. Child."},{"key":"BFnrneph2013280_CR17","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2010030315","volume":"21","author":"MA Dragon-Durey","year":"2010","unstructured":"Dragon-Durey, M. A. et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J. Am. Soc. Nephrol. 21, 2180\u20132187 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013280_CR18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport, M. J. Complement. First of two parts. N. Engl. J. Med. 344, 1058\u20131066 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013280_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785\u2013797 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrneph2013280_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","volume":"104","author":"PJ Lachmann","year":"2009","unstructured":"Lachmann, P. J. The amplification loop of the complement pathways. Adv. Immunol. 104, 115\u2013149 (2009).","journal-title":"Adv. Immunol."},{"key":"BFnrneph2013280_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","volume":"48","author":"TM Woodruff","year":"2011","unstructured":"Woodruff, T. M., Nandakumar, K. S. & Tedesco, F. Inhibiting the C5-C5a receptor axis. Mol. Immunol. 48, 1631\u20131642 (2011).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2013280_CR22","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.4049\/jimmunol.119.6.2024","volume":"119","author":"ER Podack","year":"1977","unstructured":"Podack, E. R., Kolb, W. P. & Muller-Eberhard, H. J. The SC5b-7 complex: formation, isolation, properties, and subunit composition. J. Immunol. 119, 2024\u20132029 (1977).","journal-title":"J. Immunol."},{"key":"BFnrneph2013280_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel, P. F. & Skerka, C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729\u2013740 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph2013280_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/humu.20435","volume":"28","author":"RE Saunders","year":"2007","unstructured":"Saunders, R. E. et al. The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum. Mutat. 28, 222\u2013234 (2007).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2013280_CR25","unstructured":"FH aHUS Mutation Database [online] , (2007)."},{"key":"BFnrneph2013280_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1086\/318203","volume":"68","author":"A Richards","year":"2001","unstructured":"Richards, A. et al. Factor H mutations in hemolytic uremic syndrome cluster in exons 18\u201320, a domain important for host cell recognition. Am. J. Hum. Genet. 68, 485\u2013490 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2013280_CR27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli, J. et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108, 1267\u20131279 (2006).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","volume":"53","author":"P Warwicker","year":"1998","unstructured":"Warwicker, P. et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int. 53, 836\u2013844 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph2013280_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1172\/JCI16651","volume":"111","author":"T Manuelian","year":"2003","unstructured":"Manuelian, T. et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J. Clin. Invest. 111, 1181\u20131190 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013280_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2011-03-339903","volume":"119","author":"NJ Francis","year":"2012","unstructured":"Francis, N. J. et al. A novel hybrid CFH\/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood 119, 591\u2013601 (2012).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR31","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00467-013-2560-2","volume":"28","author":"SJ Eyler","year":"2013","unstructured":"Eyler, S. J. et al. A novel hybrid CFHR1\/CFH gene causes atypical hemolytic uremic syndrome. Pediatr. Nephrol. 28, 2221\u20132225 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2013280_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1681\/ASN.2004050380","volume":"16","author":"MA Dragon-Durey","year":"2005","unstructured":"Dragon-Durey, M. A. et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol 16, 555\u2013563 (2005).","journal-title":"J. Am. Soc. Nephrol"},{"key":"BFnrneph2013280_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2215\/CJN.01260212","volume":"8","author":"J Hofer","year":"2013","unstructured":"Hofer, J. et al. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 8, 407\u2013415 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2013280_CR34","doi-asserted-by":"publisher","unstructured":"Sinha, A. et al. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Kidney Int. http:\/\/dx.doi.org\/10.1038\/ki.2013.373","DOI":"10.1038\/ki.2013.373"},{"key":"BFnrneph2013280_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","volume":"110","author":"M Jozsi","year":"2007","unstructured":"Jozsi, M. et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 110, 1516\u20131518 (2007).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR36","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","volume":"111","author":"M Jozsi","year":"2008","unstructured":"Jozsi, M. et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood 111, 1512\u20131514 (2008).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR37","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards, A. et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl Acad. Sci. USA 100, 12966\u201312971 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013280_CR38","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","volume":"362","author":"M Noris","year":"2003","unstructured":"Noris, M. et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362, 1542\u20131547 (2003).","journal-title":"Lancet"},{"key":"BFnrneph2013280_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","volume":"45","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh, D. et al. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol. Immunol. 45, 95\u2013105 (2008).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2013280_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1073\/pnas.0603420103","volume":"104","author":"E Goicoechea de Jorge","year":"2007","unstructured":"Goicoechea de Jorge, E. et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc. Natl Acad. Sci. USA 104, 240\u2013245 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013280_CR41","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fremeaux-Bacchi","year":"2008","unstructured":"Fremeaux-Bacchi, V. et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112, 4948\u20134952 (2008).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye, M. et al. Mutations in thrombomodulin in hemolytic-uremic syndrome. N. Engl. J. Med. 361, 345\u2013357 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013280_CR43","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga, T. K., Nishimura, C. J., Weaver, A. E., Frees, K. L. & Smith, R. J. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum. Mutat. 31, E1445\u2013E1460 (2010).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2013280_CR44","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1021\/cr1004106","volume":"111","author":"YV Shulga","year":"2011","unstructured":"Shulga, Y. V., Topham, M. K. & Epand, R. M. Regulation and functions of diacylglycerol kinases. Chem. Rev. 111, 6186\u20136208 (2011).","journal-title":"Chem. Rev."},{"key":"BFnrneph2013280_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire, M. et al. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat. Genet. 45, 531\u2013536 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph2013280_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","volume":"24","author":"E Bresin","year":"2013","unstructured":"Bresin, E. et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J. Am. Soc. Nephrol. 24, 475\u2013486 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013280_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ajkd.2012.07.028","volume":"61","author":"J Schmidtko","year":"2013","unstructured":"Schmidtko, J., Peine, S., El-Housseini, Y., Pascual, M. & Meier, P. Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am. J. Kidney Dis. 61, 289\u2013299 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2013280_CR48","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre, C. M. et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 368, 2169\u20132181 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013280_CR49","doi-asserted-by":"publisher","first-page":"e003573","DOI":"10.1136\/bmjopen-2013-003573","volume":"3","author":"J Rathbone","year":"2013","unstructured":"Rathbone, J. et al. A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS). BMJ Open 3, e003573 (2013).","journal-title":"BMJ Open"},{"key":"BFnrneph2013280_CR50","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc, A. L. et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 18, 2392\u20132400 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013280_CR51","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/ndt\/gfl127","volume":"21","author":"D Patschan","year":"2006","unstructured":"Patschan, D. et al. Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome. Nephrol. Dial. Transplant. 21, 1549\u20131554 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013280_CR52","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","volume":"114","author":"C Abarrategui-Garrido","year":"2009","unstructured":"Abarrategui-Garrido, C., Martinez-Barricarte, R., Lopez-Trascasa, M., de Cordoba, S. R. & Sanchez-Corral, P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 114, 4261\u20134271 (2009).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR53","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","volume":"119","author":"LT Roumenina","year":"2012","unstructured":"Roumenina, L. T. et al. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119, 4182\u20134191 (2012).","journal-title":"Blood"},{"key":"BFnrneph2013280_CR54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ajt.12077","volume":"13","author":"M Le Quintrec","year":"2013","unstructured":"Le Quintrec, M. et al. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am. J. Transplant. 13, 663\u2013675 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2013280_CR55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00467-002-0973-4","volume":"18","author":"A Ozel","year":"2003","unstructured":"Ozel, A., Caliskan, U. & Gucer, S. Peripheral gangrene complicating hemolytic uremic syndrome in a child. Pediatr. Nephrol. 18, 465\u2013467 (2003).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2013280_CR56","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s004670050058","volume":"14","author":"BS Kaplan","year":"2000","unstructured":"Kaplan, B. S. et al. Peripheral gangrene complicating idiopathic and recessive hemolytic uremic syndromes. Pediatr. Nephrol. 14, 985\u2013989 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2013280_CR57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1088\/0143-0815\/11\/4\/004","volume":"11","author":"S Singh","year":"1990","unstructured":"Singh, S., de Trafford, J. C., Goss, D. E., Baskerville, P. A. & Roberts, V. C. Ultrasound imaging of digital arteries. Clin. Phys. Physiol. Meas. 11, 313\u2013317 (1990).","journal-title":"Clin. Phys. Physiol. Meas."},{"key":"BFnrneph2013280_CR58","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1046\/j.1523-1755.2003.00831.x","volume":"63","author":"GS Hill","year":"2003","unstructured":"Hill, G. S., Heudes, D. & Bariety, J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int. 63, 1027\u20131036 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2013280_CR59","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ki.1996.40","volume":"49","author":"G Remuzzi","year":"1996","unstructured":"Remuzzi, G. et al. Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma. Kidney Int. 49, 282\u2013286 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2013280_CR60","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.3174\/ajnr.A0965","volume":"29","author":"MD Vergouwen","year":"2008","unstructured":"Vergouwen, M. D., Adriani, K. S., Roos, Y. B., Groothoff, J. W. & Majoie, C. B. Proximal cerebral artery stenosis in a patient with hemolytic uremic syndrome. AJNR 29, e34 (2008).","journal-title":"AJNR"},{"key":"BFnrneph2013280_CR61","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/ndt\/gft340","volume":"28","author":"ZD Bekassy","year":"2013","unstructured":"Bekassy, Z. D. et al. Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions. Nephrol. Dial. Transplant. 28, 2899\u20132907 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2013280_CR62","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber, C. & Noels, H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410\u20131422 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph2013280_CR63","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1161\/01.STR.30.3.644","volume":"30","author":"M Sawada","year":"1999","unstructured":"Sawada, M. et al. Prevention of neointimal formation by a serine protease inhibitor, FUT-175, after carotid balloon injury in rats. Stroke 30, 644\u2013650 (1999).","journal-title":"Stroke"},{"key":"BFnrneph2013280_CR64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/0003319710398010","volume":"62","author":"S Tanaskovic","year":"2011","unstructured":"Tanaskovic, S., Isenovic, E. R. & Radak, D. Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy\u2014evidence from clinical studies. Angiology 62, 535\u2013542 (2011).","journal-title":"Angiology"},{"key":"BFnrneph2013280_CR65","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris, M., Mescia, F. & Remuzzi, G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat. Rev. Nephrol. 8, 622\u2013633 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2013280_CR66","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","volume":"46","author":"A Klos","year":"2009","unstructured":"Klos, A. et al. The role of the anaphylatoxins in health and disease. Mol. Immunol. 46, 2753\u20132766 (2009).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2013280_CR67","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000341336","volume":"68","author":"H Yanamoto","year":"2012","unstructured":"Yanamoto, H., Kataoka, H., Nakajo, Y. & Iihara, K. The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage. Eur. Neurol. 68, 329\u2013343 (2012).","journal-title":"Eur. Neurol."},{"key":"BFnrneph2013280_CR68","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/MOL.0b013e32830f4a06","volume":"19","author":"DO Haskard","year":"2008","unstructured":"Haskard, D. O., Boyle, J. J. & Mason, J. C. The role of complement in atherosclerosis. Curr. Opin. Lipidol. 19, 478\u2013482 (2008).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFnrneph2013280_CR69","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneph.2009.10","volume":"5","author":"MR Lilien","year":"2009","unstructured":"Lilien, M. R. & Groothoff, J. W. Cardiovascular disease in children with CKD or ESRD. Nat. Rev. Nephrol. 5, 229\u2013235 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2013280_CR70","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molimm.2006.06.020","volume":"44","author":"B Nilsson","year":"2007","unstructured":"Nilsson, B., Ekdahl, K. N., Mollnes, T. E. & Lambris, J. D. The role of complement in biomaterial-induced inflammation. Mol. Immunol. 44, 82\u201394 (2007).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2013280_CR71","doi-asserted-by":"publisher","unstructured":"A\u017eukaitis, K., Loirat, C., Malina, M., Adomaitiene, I. & Jankauskiene, A. Macrovascular involvement in a child with atypical hemolytic uremic syndrome. Pediatr. Nephrol. http:\/\/dx.doi.org\/10.1007\/s00467-013-2713-3 .","DOI":"10.1007\/s00467-013-2713-3"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.280","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T20:00:33Z","timestamp":1688932833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,14]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFnrneph2013280"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.280","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,14]]}}}